Bio Green Med Solution vs Cuprina Holdings (Cayman)
BGMS and CUPR side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BGMS and CUPR compare
Bio Green Med Solution scores higher on the StockData Score (6 against 3 for Cuprina Holdings (Cayman)), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BGMS | CUPR |
|---|---|---|
| Size and price | ||
| Market cap | $6.0M | – |
| Share price | $0.900 | $1.77 |
| Change, 1 year | −50.0% | −75.5% |
| Change, 5 years | −100.0% | – |
| Beta (5Y) | 0.90 | 0.88 |
| Employees | 19 | 10 |
| StockData Score | ||
| Total score | 6 (better) | 3 |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 0 | 0 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/B | 0.8× | – |
| Growth | ||
| Revenue growth (TTM) | – | 3.3% |
| Profitability | ||
| Gross margin | – | −1.3% |
| Operating margin | – | −9680% |
| Net margin | – | −9367% |
| FCF margin | – | −18423% |
| Return on equity | −40.8% (better) | −1569% |
| Return on invested capital | −159% | – |
| Financial health | ||
| Debt / equity | 0.00 | 0.03 (better) |
| Interest coverage | – | −328.0× |
| Current ratio | 8.63 (better) | 2.35 |
| Altman Z-score | −76.30 | – |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.00% | – |
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 1.5% | 0.00% |
| Held by insiders | 33.4% | – |
| Insider net buying, 12 months | −$48.5K | – |
Go deeper
- BGMS stock overview
- BGMS income statement
- BGMS valuation and score
- CUPR stock overview
- CUPR income statement
- CUPR valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.